Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-21-065314

Chief Scientific Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-16 Grant or award : show line 1 in the form +40,000 61,898 D
Loading xslF345X03/doc4.xml…